KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,050,000 shares, a growth of 5.6% from the March 15th total of 994,500 shares. Based on an average daily volume of 95,500 shares, the short-interest ratio is currently 11.0 days.
Wall Street Analyst Weigh In
Separately, B. Riley reiterated a “buy” rating and issued a $4.00 price objective on shares of KORU Medical Systems in a research note on Thursday, March 14th.
View Our Latest Research Report on KORU Medical Systems
Institutional Investors Weigh In On KORU Medical Systems
KORU Medical Systems Trading Up 3.4 %
KORU Medical Systems stock opened at $2.15 on Wednesday. The firm has a 50 day moving average of $2.19 and a 200 day moving average of $2.27. The firm has a market capitalization of $98.28 million, a price-to-earnings ratio of -7.41 and a beta of 0.53. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $4.48. The company has a current ratio of 4.55, a quick ratio of 3.77 and a debt-to-equity ratio of 0.02.
KORU Medical Systems (NASDAQ:KRMD – Get Free Report) last released its earnings results on Wednesday, March 13th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. The company had revenue of $7.19 million during the quarter, compared to analyst estimates of $7.01 million. KORU Medical Systems had a negative net margin of 48.18% and a negative return on equity of 27.82%. As a group, research analysts predict that KORU Medical Systems will post -0.15 earnings per share for the current year.
KORU Medical Systems Company Profile
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
See Also
- Five stocks we like better than KORU Medical Systems
- Best Stocks Under $5.00
- Prologis Stock Leading U.S. Logistics Boom
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
- How to Read Stock Charts for Beginners
- Are We in a Bull Market? 4 Factors that Determine a Bull Market
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.